Vitetta ES - Search Results

1

Cancer dormancy: opportunities for new therapeutic approaches.

Uhr JW, Scheuermann RH, Street NE, Vitetta ES. Uhr JW, et al. Among authors: vitetta es. Nat Med. 1997 May;3(5):505-9. doi: 10.1038/nm0597-505. Nat Med. 1997. PMID: 9142117 Review. No abstract available.

2

Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.

Racila E, Scheuermann RH, Picker LJ, Yefenof E, Tucker T, Chang W, Marches R, Street NE, Vitetta ES, Uhr JW. Racila E, et al. Among authors: vitetta es. J Exp Med. 1995 Apr 1;181(4):1539-50. doi: 10.1084/jem.181.4.1539. J Exp Med. 1995. PMID: 7535341 Free PMC article.

3

Role of antibody signaling in inducing tumor dormancy.

Uhr JW, Marches R, Racila E, Tucker TF, Hsueh R, Street NE, Vitetta ES, Scheuermann RH. Uhr JW, et al. Among authors: vitetta es. Adv Exp Med Biol. 1996;406:69-74. doi: 10.1007/978-1-4899-0274-0_7. Adv Exp Med Biol. 1996. PMID: 8910672 Review. No abstract available.

4

B-cell tolerance. II. Trinitrophenyl human gamma globulin-induced tolerance in adult and neonatal murine B cells responsive to thymus-dependent and independent forms of the same hapten.

Cambier JC, Vitetta ES, Uhr JW, Kettman JR. Cambier JC, et al. Among authors: vitetta es. J Exp Med. 1977 Mar 1;145(3):778-83. doi: 10.1084/jem.145.3.778. J Exp Med. 1977. PMID: 95788 Free PMC article.

5

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin.

Ghetie MA, Tucker K, Richardson J, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: vitetta es. Blood. 1992 Nov 1;80(9):2315-20. Blood. 1992. PMID: 1384801 Free article.

6

Cancer dormancy: studies of the murine BCL1 lymphoma.

Uhr JW, Tucker T, May RD, Siu H, Vitetta ES. Uhr JW, et al. Among authors: vitetta es. Cancer Res. 1991 Sep 15;51(18 Suppl):5045s-5053s. Cancer Res. 1991. PMID: 1884380

7

Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites.

Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES. Ghetie MA, et al. Among authors: vitetta es. Cancer Res. 1991 Nov 1;51(21):5876-80. Cancer Res. 1991. PMID: 1933855

8

Monoclonal antibodies as carriers of toxins.

Uhr JW, Fulton RJ, Till MA, May RD, Vitetta ES. Uhr JW, et al. Among authors: vitetta es. Prog Clin Biol Res. 1989;288:403-12. Prog Clin Biol Res. 1989. PMID: 2785694 No abstract available.

9

Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells.

Scheuermann RH, Racila E, Tucker T, Yefenof E, Street NE, Vitetta ES, Picker LJ, Uhr JW. Scheuermann RH, et al. Among authors: vitetta es. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4048-52. doi: 10.1073/pnas.91.9.4048. Proc Natl Acad Sci U S A. 1994. PMID: 7513431 Free PMC article.

10

Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.

Vitetta ES, Uhr JW. Vitetta ES, et al. Cancer Res. 1994 Oct 15;54(20):5301-9. Cancer Res. 1994. PMID: 7923157 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters